The pharmaceutical giant, whose China chief is now under investigation, was previously at the centre of insurance scam cases, ...

AstraZeneca is under scrutiny in China — as its top executive there and other personnel are being investigated by authorities ...

Three phase 3 trials will assess datopotamab deruxtecan-based treatments in patients with nonsquamous non-small cell lung ...

As AstraZeneca’s chronic obstructive pulmonary disease drug Breztri continues climbing toward blockbuster status, the Big Pharma is broadening its efforts to support people with COPD. | As AstraZeneca ...

AstraZeneca said its China president Leon Wang is under investigation and the drugmaker would cooperate with Chinese ...

The pharma giant confirmed that Wang Lei, the executive vice president who oversaw AstraZeneca’s rapid expansion in China, is ...

The first patients have been dosed in three global, randomized phase 3 trials evaluating the efficacy and safety of ...

One of the most magnificent stocks healthcare investors can buy for the long haul is U.K.-based AstraZeneca, which is trading at around $76 right now. The company has a robust business that generates ...

CNW/ - The 2025 Lung Ambition Awards – a Canadian-based lung cancer research award program – is now open for submissions. For ...

China’s probe into AstraZeneca Plc has reached its uppermost echelons, ensnaring local president Leon Wang and throwing into question the future of the most successful Western pharmaceutical company ...

The symposium took place during the 2024 European Society for Medical Oncology (ESMO) Congress in Barcelona, Spain, with the ...